Cited by 108Virus-based gene therapy researchRetinal Development and DisordersRNA Interference and Gene Delivery

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach

Open access

Mowat, F M, Gornik, K R, Dinculescu, A, Boye, S L, Hauswirth, W W, Petersen-Jones, S M, Bartoe, J T·2014·Gene Therapy

DOI 10.1038/gt.2013.64PMC PMC3880610

Open this paper in CoChat — free account

Abstract

Recombinant adeno-associated viruses are important vectors for retinal gene delivery. Currently utilized vectors have relatively slow onset, and for efficient transduction it is necessary to deliver treatment subretinally, with the potential for damage to the retina. Amino-acid substitutions in the viral capsid improve efficiency in rodent eyes by evading host responses. As dogs are important large animal models for human retinitis pigmentosa, we evaluated the speed and efficiency of retinal transduction using capsid-mutant vectors injected both subretinally and intravitreally. We evaluated AAV serotypes 2 and 8 with amino-acid substitutions of surface-exposed capsid tyrosine residues. The chicken beta-actin promoter was used to drive green fluorescent protein expression. Twelve normal adult beagles were injected; four dogs received intravitreal injections and eight dogs received subretinal injections. Capsid-mutant viruses tested included AAV2(quad Y-F) (intravitreal and subretinal) and self-complementary scAAV8(Y733F) (subretinal only). Contralateral control eyes received injections of scAAV5 (subretinal) or scAAV2 (intravitreal). Subretinally delivered vectors had a faster expression onset than intravitreally delivered vectors. Subretinally delivered scAAV8(Y733F) had a faster onset of expression than scAAV5. All subretinally injected vector types transduced the outer retina with high efficiency and the inner retina with moderate efficiency. Intravitreally delivered AAV2(quad Y-F) had a marginally higher efficiency of transduction of both outer retinal and inner retinal cells than scAAV2. Because of their rapid expression onset and efficient transduction, subretinally delivered capsid-mutant AAV8 vectors may increase the efficacy of gene therapy treatment for rapid photoreceptor degenerative diseases. With further refinement, capsid-mutant AAV2 vectors show promise for retinal gene delivery from an intravitreal approach.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/gt.2013.64

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Self-citation
Gene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202
Self-citation
Untitled work
(1984) · PubMed · Cited by 1,200
Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Self-citation
Ectopic Expression of a Microbial-Type Rhodopsin Restores Visual Responses in Mice with Photoreceptor Degeneration
Bi, A., Cui, J., Ma, Y.-P., Olshevskaya, E. V., Pu, M., Dizhoor, A. M., & Pan, Z. (2006) · Neuron · doi:10.1016/j.neuron.2006.02.026 · Cited by 790
In Vivo–Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous
Dalkara, D., Byrne, L. C., Klimczak, R. R., Visel, M., Yin, L., Merigan, W. H., Flannery, J. G., & Schaffer, D. V. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005708 · Cited by 734
Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years
Jacobson, S. G. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.298 · Cited by 639
Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses
Zhong, L., Li, B., Mah, C. S., Govindasamy, L., Agbandje-McKenna, M., Cooper, M., Herzog, R. W., Zolotukhin, I., Warrington, K. H., Weigel-Van Aken, K. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802866105 · Cited by 558

Show all 64 references

Sorted by citations

Progresses towards safe and efficient gene therapy vectors
Chira, S., Jackson, C. S., Oprea, I. I., Öztürk, F., Pepper, M. S., Diaconu, I., Braicu, C., Ráduly, L., Călin, G. A., & Berindan‐Neagoe, I. (2015) · Oncotarget · doi:10.18632/oncotarget.5169 · Cited by 227
A robust activity marking system for exploring active neuronal ensembles
Sørensen, A. T., Cooper, Y. A., Baratta, M. V., Weng, F., Zhang, Y., Ramamoorthi, K., Fropf, R., LaVerriere, E., Xue, J., Young, A., et al. (2016) · eLife · doi:10.7554/elife.13918 · Cited by 199
Vector platforms for gene therapy of inherited retinopathies
Trapani, I., Puppo, A., & Auricchio, A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.08.001 · Cited by 191
Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injection
Wassmer, S. J., Carvalho, L. S., György, B., Vandenberghe, L. H., & Maguire, C. A. (2017) · Scientific Reports · doi:10.1038/srep45329 · Cited by 164
Evaluation of Dose and Safety of AAV7m8 and AAV8BP2 in the Non-Human Primate Retina
Ramachandran, P. S., Lee, V., Wei, Z., Song, J. Y., Casal, G., Cronin, T., Willett, K., Huckfeldt, R., Morgan, J. I. W., Aleman, T. S., et al. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.111 · Cited by 147
AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression
Ding, K., Shen, J., Hafiz, Z., Hackett, S. F., Silva, R. L. E., Khan, M., Lorenc, V. E., Chen, D., Chadha, R., Zhang, M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129085 · Cited by 141
Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
Pavlou, M., Schön, C., Occelli, L. M., Rossi, A., Meumann, N., Boyd, R. F., Bartoe, J. T., Siedlecki, J., Gerhardt, M. J., Babutzka, S., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013392 · Cited by 135
Self-citation
In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye
Peynshaert, K., Devoldere, J., Smedt, S. C. D., & Remaut, K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.007 · Cited by 138
Seeing the light after 25 Years of retinal gene therapy
Trapani, I., & Auricchio, A. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.06.006 · Cited by 124
Gene therapy for inherited retinal diseases: Progress and possibilities
Hu, M. L., Edwards, T. L., O’Hare, F., Hickey, D. G., Wang, J.-H., Liu, Z., & Ayton, L. N. (2021) · Clinical and Experimental Optometry · doi:10.1080/08164622.2021.1880863 · Cited by 118
The pros and cons of vertebrate animal models for functional and therapeutic research on inherited retinal dystrophies
Slijkerman, R. W. N., Song, F., Astuti, G., Huynen, M. A., van Wijk, E., Stieger, K., & Collin, R. W. J. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.04.004 · Cited by 123
Morphology and Composition of the Inner Limiting Membrane: Species-Specific Variations and Relevance toward Drug Delivery Research
Peynshaert, K., Devoldere, J., Minnaert, A., Smedt, S. C. D., & Remaut, K. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1565890 · Cited by 94
Treatment of ocular disorders by gene therapy
Solinís, M. Á., del Pozo-Rodríguez, A., Apaolaza, P. S., & Rodríguez-Gascón, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.022 · Cited by 88
Preclinical dose-escalation study of intravitreal AAV-RS1 gene therapy in a mouse model of X-linked retinoschisis: dose-dependent expression and improved retinal structure and function
Bush, R. A., Zeng, Y., Colosi, P., Kjellstrom, S., Hiriyanna, S., Vijayasarathy, C., Santos, M., Li, J., Wu, Z., & Sieving, P. A. (2016) · Human Gene Therapy · doi:10.1089/hum.2015.142 · Cited by 86
Suprachoroidal delivery of viral and nonviral gene therapy for retinal diseases
Kansara, V., Muya, L., Wan, C.-R., & Ciulla, T. A. (2020) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2019.0126 · Cited by 84
Advances in gene therapy for diseases of the eye
Petit, L., Khanna, H., & Punzo, C. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.040 · Cited by 82
Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina
Boye, S. L., Alexander, J. J., Witherspoon, C. D., Boye, S. L., Peterson, J. J., Clark, M. E., Sandefer, K. J., Girkin, C. A., Hauswirth, W. W., & Gamlin, P. D. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.085 · Cited by 81
Self-citation
Assessment of AAV Vector Tropisms for Mouse and Human Pluripotent Stem Cell-Derived RPE and Photoreceptor Cells
Gonzalez-Cordero, A., Goh, D., Kruczek, K., Naeem, A., Fernando, M., kleine Holthaus, S.-M., Takaaki, M., Blackford, S. J. I., Kloc, M., Agundez, L., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.027 · Cited by 77
Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant -7m8
Khabou, H., Desrosiers, M., Winckler, C., Fouquet, S., Auregan, G., Bemelmans, A., Sahel, J., & Dalkara, D. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26031 · Cited by 71
Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications
Schön, C., Biel, M., & Michalakis, S. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.009 · Cited by 72
Assessment of Adeno-Associated Virus Serotype Tropism in Human Retinal Explants
Wiley, L. A., Burnight, E. R., Kaalberg, E. E., Jiao, C., Riker, M. J., Halder, J. A., Luse, M. A., Han, I. C., Russell, S. R., Sohn, E. H., et al. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.179 · Cited by 69
The future of retinal gene therapy: evolving from subretinal to intravitreal vector delivery
Ross, M., & Ofri, R. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.306063 · Cited by 67
“…not differ from that of WT AAV, mostly inner retinal transduction Dias et al. (2019) Dog Moderate photoreceptor transduction following IVT injection Mowat et al. (2014); Boyd et al. (2016) Sheep AAV quad (Y-F+T-V) injected IVT to sheep does not result in photoreceptor transduction Ross et al.…”
BackgroundInfluential
Non-viral delivery of chemically modified mRNA to the retina: Subretinal versus intravitreal administration
Devoldere, J., Peynshaert, K., Dewitte, H., Vanhove, C., Groef, L. D., Moons, L., Özcan, S. Y., Dalkara, D., Smedt, S. C. D., & Remaut, K. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.042 · Cited by 70
The internal limiting membrane: Roles in retinal development and implications for emerging ocular therapies
Zhang, K. Y., & Johnson, T. V. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108545 · Cited by 64
Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for ocular gene therapy development
Ciulla, T. A., Hussain, R. M., Berrocal, A. M., & Nagiel, A. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1740676 · Cited by 59
Toward smart design of retinal drug carriers: a novel bovine retinal explant model to study the barrier role of the vitreoretinal interface
Peynshaert, K., Devoldere, J., Forster, V., Picaud, S. A., Vanhove, C., Smedt, S. C. D., & Remaut, K. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1375578 · Cited by 58
A versatile toolkit for overcoming AAV immunity
Li, X., Wei, X., Lin, J., & Ou, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.991832 · Cited by 57
Gene Therapy in a Large Animal Model of PDE6A-Retinitis Pigmentosa
Mowat, F. M., Occelli, L. M., Bartoe, J. T., Gervais, K. J., Bruewer, A. R., Querubin, J. R., Dinculescu, A., Boye, S. L., Hauswirth, W. W., & Petersen‐Jones, S. M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00342 · Cited by 54
Self-citation
Mutations in the Kinesin-2 Motor KIF3B Cause an Autosomal-Dominant Ciliopathy
Cogné, B., Latypova, X., Senaratne, L. D. S., Martin, L., Koboldt, D. C., Kellaris, G., Fievet, L., Meur, G. L., Caldari, D., Debray, D., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.04.005 · Cited by 50
Self-citation
The Future Looks Brighter After 25 Years of Retinal Gene Therapy
Auricchio, A., Smith, A. J., & Ali, R. R. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.164 · Cited by 53
Has retinal gene therapy come of age? From bench to bedside and back to bench
Trapani, I., & Auricchio, A. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz130 · Cited by 55
Gene Therapy of Inherited Retinal Degenerations: Prospects and Challenges
Trapani, I., Banfi, S., Simonelli, F., Surace, E. M., & Auricchio, A. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.030 · Cited by 46
Delivering AAV to the Central Nervous and Sensory Systems
Peters, C. W., Maguire, C. A., & Hanlon, K. S. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.03.004 · Cited by 44
Prevention of Photoreceptor Cell Loss in a Cln6 Mouse Model of Batten Disease Requires CLN6 Gene Transfer to Bipolar Cells
Holthaus, S.-M. K., Ribeiro, J., Abelleira, L. E., Pearson, R. A., Durán, Y., Georgiadis, A., Sampson, R. D., Rizzi, M., Hoke, J., Maswood, R. N., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.027 · Cited by 45
Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration
Hammadi, S., Tzoumas, N., Ferrara, M., Meschede, I. P., Lo, K., Harris, C., Lako, M., & Steel, D. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082870 · Cited by 44
Local magnetic delivery of adeno-associated virus AAV2(quad Y-F)-mediated BDNF gene therapy restores hearing after noise injury
Mukherjee, S., Kuroiwa, M., Oakden, W., Paul, B. T., Noman, A., Chen, J., Lin, V., Dimitrijevic, A., Stanisz, G. J., & Le, T. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.07.013 · Cited by 42
The concept of gene therapy for glaucoma: the dream that has not come true yet
Sulak, R., Liu, X., & Smedowski, A. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.375319 · Cited by 40
Recent advances and future prospects: Current status and challenges of the intraocular injection of drugs for vitreoretinal diseases
Hashida, N., & Nishida, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114870 · Cited by 37
Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease
Holthaus, S.-M. K., Aristorena, M., Maswood, R. N., Semenyuk, O., Hoke, J., Hare, A., Smith, A. J., Mole, S., & Ali, R. R. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.038 · Cited by 40
Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs
Boyd, R. F., Sledge, D. G., Boye, S. L., Boye, S. E., Hauswirth, W. W., Komáromy, A. M., Petersen‐Jones, S. M., & Bartoe, J. T. (2015) · Gene Therapy · doi:10.1038/gt.2015.96 · Cited by 40
Self-citation
Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs
Boyd, R. F., Boye, S. L., Conlon, T. J., Erger, K. E., Sledge, D. G., Langohr, I. M., Hauswirth, W. W., Komáromy, A. M., Boye, S. E., Petersen-Jones, S. M., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.31 · Cited by 37
Self-citation
Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors
Chen, M., Maeng, K., Nawab, A., Francois, R. A., Bray, J. K., Reinhard, M. K., Boye, S. L., Hauswirth, W. W., Kaye, F. J., Aslanidi, G., et al. (2017) · Human Gene Therapy Methods · doi:10.1089/hgtb.2016.089 · Cited by 36
Self-citation
Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy
Sanjurjo-Soriano, C., & Kalatzis, V. (2018) · Neural Plasticity · doi:10.1155/2018/5056279 · Cited by 38
Novel Adeno-associated Viruses Derived From Pig Tissues Transduce Most Major Organs in Mice
Bello, A., Chand, A., Aviles, J., Soule, G., Auricchio, A., & Kobinger, G. (2014) · Scientific Reports · doi:10.1038/srep06644 · Cited by 36
Gene Supplementation Rescues Rod Function and Preserves Photoreceptor and Retinal Morphology in Dogs, Leading the Way Toward Treating Human PDE6A -Retinitis Pigmentosa
Occelli, L. M., Schön, C., Seeliger, M. W., Biel, M., Michalakis, S., & Petersen‐Jones, S. M. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.155 · Cited by 35
Self-citation
A novel retinal ganglion cell promoter for utility in AAV vectors
Hanlon, K. S., Chadderton, N., Palfi, A., Blanco Fernandez, A., Humphries, P., Kenna, P. F., Millington-Ward, S., & Farrar, G. J. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00521 · Cited by 34
Vitrectomy Before Intravitreal Injection of AAV2/2 Vector Promotes Efficient Transduction of Retinal Ganglion Cells in Dogs and Nonhuman Primates
Tshilenge, K., Ameline, B., Weber, M., Mendes-Madeira, A., Nédellec, S., Biget, M., Provost, N., Libeau, L., Blouin, V., Deschamps, J., et al. (2016) · Human Gene Therapy Methods · doi:10.1089/hgtb.2016.034 · Cited by 34
The obstacle course to the inner retina: Hyaluronic acid-coated lipoplexes cross the vitreous but fail to overcome the inner limiting membrane
Devoldere, J., Wels, M., Peynshaert, K., Dewitte, H., Smedt, S. C. D., & Remaut, K. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.05.023 · Cited by 30
Crx Rdy Cat: A Large Animal Model for CRX -Associated Leber Congenital Amaurosis
Occelli, L. M., Tran, N. M., Narfström, K. L., Chen, S., & Petersen‐Jones, S. M. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19444 · Cited by 29
Self-citation
Gene therapy for inherited retinal degenerations: initial successes and future challenges
Gupta, P. R., & Huckfeldt, R. M. (2017) · Journal of Neural Engineering · doi:10.1088/1741-2552/aa7a27 · Cited by 32
Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation.
Igarashi, T., Miyake, K., Kobayashi, M., Kameya, S., Fujimoto, C., Nakamoto, K., Takahashi, H., Igarashi, T., Miyake, N., Iijima, O., et al. (2016) · Europe PMC (PubMed Central) · Cited by 28
Long-Term Effects of Retinal Gene Therapy in Childhood Blindness
Wright, A. F. (2015) · New England Journal of Medicine · doi:10.1056/nejme1503419 · Cited by 28
Update on ocular gene therapy and advances in treatment of inherited retinal diseases and exudative macular degeneration
Garoon, R. B., & Stout, J. T. (2016) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000256 · Cited by 25
X-Linked RetinoschisisPreprint
Ku, C. A., Wei, L. W., & Sieving, P. A. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041288 · Cited by 24
Concepts and Strategies in Retinal Gene Therapy
Aguirre, G. D. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22978 · Cited by 24
Engineered viral vectors for functional interrogation, deconvolution, and manipulation of neural circuits
Sun, S., & Schaffer, D. V. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.12.011 · Cited by 24
Challenging glaucoma with emerging therapies: an overview of advancements against the silent thief of sight
Sarkis, S., Chamard, C., Johansen, B., Daïen, V., & Michon, F. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1527319 · Cited by 27
Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques
Kovacs, K. D., Ciulla, T. A., & Kiss, S. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2121646 · Cited by 20
Early-Onset Progressive Degeneration of the Area Centralis in RPE65-Deficient Dogs
Mowat, F. M., Gervais, K. J., Occelli, L. M., Annear, M. J., Querubin, J. R., Bainbridge, J. W., Smith, A. J., Ali, R. R., & Petersen‐Jones, S. M. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21930 · Cited by 21
Self-citation
Gene Therapy to the Retina and the Cochlea
Crane, R., Conley, S. M., Al‐Ubaidi, M. R., & Naash, M. I. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.652215 · Cited by 24
Antiangiogenic Eye Gene Therapy
Corydon, T. J. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.064 · Cited by 20
Transduction Patterns of Adeno-associated Viral Vectors in a Laser-Induced Choroidal Neovascularization Mouse Model
Lee, S. H., Kim, Y.-S., Nah, S. K., Kim, H. J., Park, H. Y., Yang, J. Y., Park, K., & Park, T. K. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.01.008 · Cited by 18
Retina transduction by rAAV2 after intravitreal injection: Comparison between mouse and rat
Dias, M. S., Araujo, V. G., Vasconcelos, T., Li, Q., Hauswirth, W. W., Linden, R., & Petrs-Silva, H. (2019) · Gene Therapy · doi:10.1038/s41434-019-0100-9 · Cited by 17
Self-citation
Trans-ocular Electric Current In Vivo Enhances AAV-Mediated Retinal Gene Transduction after Intravitreal Vector Administration
Song, H., Bush, R. A., Zeng, Y., Qian, H., Wu, Z., & Sieving, P. A. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.12.006 · Cited by 17
Subretinal Rather Than Intravitreal Adeno-Associated Virus-Mediated Delivery of a Complement Alternative Pathway Inhibitor Is Effective in a Mouse Model of RPE Damage
Annamalai, B., Parsons, N., Nicholson, C., Obert, E., Jones, B., & Rohrer, B. (2021) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.62.4.11 · Cited by 16
Evaluation of Photoreceptor Transduction Efficacy of Capsid-Modified Adeno-Associated Viral Vectors Following Intravitreal and Subretinal Delivery in Sheep
Ross, M., Obolensky, A., Averbukh, E., Ezra-Elia, R., Yamin, E., Honig, H., Dvir, H., Rosov, A., Hauswirth, W. W., Gootwine, E., et al. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.023 · Cited by 16
Self-citation
Retinal gene therapy: current progress and future prospects
Ku, C. A., & Pennesi, M. E. (2015) · Expert Review of Ophthalmology · doi:10.1586/17469899.2015.1035711 · Cited by 16
Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies
Panikker, P., Roy, S., Ghosh, A., Poornachandra, B., & Ghosh, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.906482 · Cited by 17
Development of a translatable gene augmentation therapy for CNGB1-retinitis pigmentosa
Occelli, L. M., Zobel, L., Stoddard, J., Wagner, J., Pasmanter, N., Querubin, J. R., Renner, L. M., Reynaga, R., Winkler, P. A., Sun, K., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.04.005 · Cited by 14
Self-citation
Outer retinal transduction by AAV2-7m8 following intravitreal injection in a sheep model of CNGA3 achromatopsia
Ross, M., Obolensky, A., Averbukh, E., Desrosiers, M., Ezra-Elia, R., Honig, H., Yamin, E., Rosov, A., Dvir, H., Gootwine, E., et al. (2022) · Gene Therapy · doi:10.1038/s41434-021-00306-1 · Cited by 13
AAVrh-10 transduces outer retinal cells in rodents and rabbits following intravitreal administration
Zeng, Y., Qian, H., Wu, Z., Marangoni, D., Sieving, P. A., & Bush, R. A. (2019) · Gene Therapy · doi:10.1038/s41434-019-0094-3 · Cited by 12
Improved gene therapy for MFRP deficiency-mediated retinal degeneration by knocking down endogenous bicistronic Mfrp and Ctrp5 transcript
Tian, X., Zheng, Q., Xie, J., Zhou, Q., Liang, L., Xu, G., Chen, H., Ling, C., & Lu, D. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.05.001 · Cited by 12
Challenges in AAV-Based Retinal Gene Therapies and the Role of Magnetic Nanoparticle Platforms
Siontas, O., & Ahn, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237385 · Cited by 13
Intravitreal Gene Therapy Preserves Retinal Function in a Canine Model of CLN2 Neuronal Ceroid Lipofuscinosis
Kick, G. R., Whiting, R. E. H., Ota‐Kuroki, J., Castaner, L. J., Morgan-Jack, B. R., Sabol, J. C., Meiman, E. J., Ortiz, F., & Katz, M. L. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109344 · Cited by 12
Synergistic inhibition of PARP-1 and NF-κB signaling downregulates immune response against recombinant AAV2 vectors during hepatic gene therapy
Hareendran, S., Ramakrishna, B., & Jayandharan, G. R. (2016) · European Journal of Immunology · doi:10.1002/eji.201545867 · Cited by 10
Peripapillary Intravitreal Injection Improves AAV-Mediated Retinal Transduction
Madrakhimov, S. B., Yang, J. Y., Ahn, D. H., Han, J. W., Ha, T. H., & Park, T. K. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.03.018 · Cited by 10
Differential targeting of feline photoreceptors by recombinant adeno-associated viral vectors: implications for preclinical gene therapy trials
Minella, A., Mowat, F. M., Willett, K. L., Sledge, D. G., Bartoe, J. T., Bennett, J., & Petersen‐Jones, S. M. (2014) · Gene Therapy · doi:10.1038/gt.2014.65 · Cited by 9
Self-citation
scAAV2-Mediated C3 Transferase Gene Therapy in a Rat Model with Retinal Ischemia/Reperfusion Injuries
Tan, J., Zhang, X., Li, D., Liu, G., Wang, Y., Zhang, D., Wang, X., Tian, W., Dong, X., Zhou, L., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.04.014 · Cited by 9
Non‐invasive optical coherence tomography angiography: A comparison with fluorescein and indocyanine green angiography in normal adult dogs and cats
Occelli, L. M., Pirie, C. G., & Petersen‐Jones, S. M. (2022) · Veterinary Ophthalmology · doi:10.1111/vop.12973 · Cited by 8
Self-citation
Phenotypic characterization of complete CSNB in the inbred research beagle: how common is CSNB in research and companion dogs?
Oh, A., Loew, E. R., Foster, M. L., Davidson, M. G., English, R. V., Gervais, K. J., Herring, I. P., & Mowat, F. M. (2018) · Documenta Ophthalmologica · doi:10.1007/s10633-018-9653-y · Cited by 8
Self-citation
“Para-retinal” Vector Administration into the Deep Vitreous Enhances Retinal Transgene Expression
Zeng, Y., Boyd, R. F., Bartoe, J. T., Wiley, H. E., Marangoni, D., Wei, L. L., & Sieving, P. A. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.06.015 · Cited by 7
Self-citation
Efficient retinal ganglion cells transduction by retro-orbital venous sinus injection of AAV-PHP.eB in mature mice
Tang, M., Zhong, L., Rong, H., Li, K., Ye, M., Peng, J., & Ge, J. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.109931 · Cited by 6
Pre-retinal delivery of recombinant adeno-associated virus vector significantly improves retinal transduction efficiency
Zhang, H., Sajdak, B. S., Merriman, D. K., Carroll, J., & Lipinski, D. M. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.06.005 · Cited by 6
Viral Vector Technologies and Strategies: Improving on Nature
Croze, R. H., Kotterman, M. A., Burns, C. H., Schmitt, C. E., Quezada, M., Schaffer, D. V., Kirn, D. H., & Francis, P. J. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000361 · Cited by 5
Gene Therapy for Inherited Retinopathies: Update on Development Progress
Sun, S. Y., & Montezuma, S. R. (2018) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126418783934 · Cited by 5
Natural history of retinal degeneration in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses
Murray, S. J., & Mitchell, N. L. (2022) · Scientific Reports · doi:10.1038/s41598-022-07612-7 · Cited by 5
Delivery of Genetic Information: Viral Vector and Nonviral Vector Gene Therapies
Gemayel, M. C., Byrne, L. C., Ciulla, T. A., & Sahel, J. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000360 · Cited by 5
DNA- and RNA-based Gene Therapies in Ophthalmology
Ciulla, T. A., Pennesi, M. E., Kiss, S., & Cunningham, E. T. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000359 · Cited by 4
Suppressing microtubule detyrosination augments adeno-associated virus 2 endosomal escape and gene delivery
Tripathi, S., Huda, S., Kar, J., Chandra, D., Jayandharan, G. R., & Mohan, N. (2025) · Journal of Cell Science · doi:10.1242/jcs.264190 · Cited by 3
Intravitreal AAV2 gene delivery to feline retinal ganglion cells
Oikawa, K., Eaton, J. S., Kiland, J. A., Torné, O., Mathu, V., Nickells, R. W., & McLellan, G. J. (2024) · Vision Research · doi:10.1016/j.visres.2024.108519 · Cited by 3
Genetic Variants and Impact in PDE6B Rod-Cone Dystrophy
Watson, C. J. G., Nash, B. M., Loi, T. H., Grigg, J., & Jamieson, R. V. (2021) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-15-9184-6_15 · Cited by 2
Metabolic changes and retinal remodeling in Heterozygous CRX mutant cats (CRX)
Occelli, L. M., Jones, B. W., Cervantes, T. J., & Petersen‐Jones, S. M. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109630 · Cited by 2
Self-citation
Virus Vectors for Optogenetic Prosthetization of the Retina
Rotov, A. Y., Nikolaeva, D. A., Astakhova, L. A., & Firsov, M. L. (2020) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-020-00911-4 · Cited by 2
Chromophore-loaded CRALBP mutant proteins restore rod function in chromophore-deficient mice
Kolesnikov, A. V., Aeschimann, W., Cullity, J., Halabi, M., Kiser, P. D., Stocker, A., & Kefalov, V. J. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201701 · Cited by 1
AI-engineered AAV capsid enables intravitreal delivery for the treatment of diverse retinal degenerations
Cui, M., Liu, H., Cai, L., Zhang, Q., Yuan, L., Gao, C., Li, C., Xi, J., Li, Y., Wu, C., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201806 · Cited by 1
Ocular Gene Therapies
Michalakis, S., Gerhardt, M.-J., Priglinger, C., & Priglinger, S. G. (2021) · Springer eBooks · doi:10.1007/978-3-319-90495-5_150-1 · Cited by 1
Glaucoma - Recent Advances and New Perspectives
Davey, P. G. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.98102 · Cited by 1
A novel capsid-XL32-derived adeno-associated virus serotype prompts retinal tropism and ameliorates choroidal neovascularization
Luo, L., Xu, J., Wang, B.-Q., Chen, C., Chen, X., Hu, Q., Wang, Y., Zhang, W.-Y., Jiang, W., Li, X.-T., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122403 · Cited by 2
Ocular Gene Therapies
Michalakis, S., Gerhardt, M.-J., Priglinger, C., & Priglinger, S. G. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_150 · Cited by 1
Perspective on Gene Therapy for Glaucoma
Dias, M. S., Araújo, V. G., Lani‐Louzada, R., Linden, R., Ribas, V. T., & Petrs‐Silva, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104295 · Cited by 1

Authors: Mowat, F. M., Gornik, K. R., Dinculescu, A., Boye, S. L., Hauswirth, W. W., Petersen-Jones, S. M., & Bartoe, J. T.
Affiliations: Michigan State University (US)
University of Florida Health (US)
ORCID: Mowat, F M
Gornik, K R
Dinculescu, A
Boye, S L
Hauswirth, W W
Venue: Gene Therapy
Publisher: Springer Science and Business Media LLC
Published: 2013-11-14
Volume: 21
Issue: 1
Pages: 96-105
ISSN: 0969-7128 (ISSN-L)
1476-5462
DOI: 10.1038/gt.2013.64
PMC: PMC3880610
OpenAlex: W2011980241
Cited by: 108
References: 64
Citations by year: 2026: 3 · 2025: 3 · 2024: 4 · 2023: 8 · 2022: 9 · 2021: 18 · 2020: 9 · 2019: 7 · 2018: 11 · 2017: 12 · 2016: 11 · 2015: 9 · 2014: 4
FWCI: 5.29
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Gene Therapy (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Eye Institute (P30EY021721, R24EY022023, EY-021721, R01EY017549)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords: adeno-associated virus vectors, retinal gene delivery, subretinal injection, intravitreal injection, canine retina, retinitis pigmentosa, AAV2, AAV8, self-complementary AAV, photoreceptor degeneration, beagle dogs
MeSH terms: Dependovirus, Animals, Capsid, Dogs, Female, Genetic Vectors, Humans, Male, Mutation, Recombinant Proteins, Retina, Transduction, Genetic, Tyrosine, Amino Acid Substitution, Viral Tropism, Injections, Intraocular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks